Clarius Group, LLC Vertex Pharmaceuticals Inc Transaction History

Clarius Group, LLC

$1.44 Billion
Q4 2024

A detailed history of Clarius Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Clarius Group, LLC holds 1,378 shares of VRTX stock, worth $663,713. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,378

Previous 1,508 8.62%

Holding current value

$663,713

Previous $701,000 20.97%

% of portfolio

0.04%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$396.64 - $516.74 $51,563 - $67,176	-130 Reduced 8.62%	1,378 $554,000
Q3 2024 Oct 09, 2024	SELL	$460.0 - $505.78 $22,080 - $24,277	-48 Reduced 3.08%	1,508 $701,000
Q2 2024 Jul 11, 2024	SELL	$392.81 - $485.53 $36,924 - $45,639	-94 Reduced 5.7%	1,556 $729,000
Q1 2024 Apr 17, 2024	SELL	$407.69 - $446.08 $125,568 - $137,392	-308 Reduced 15.73%	1,650 $689,000
Q4 2023 Jan 29, 2024	SELL	$343.0 - $410.68 $43,561 - $52,156	-127 Reduced 6.09%	1,958 $796,000
Q3 2023 Oct 19, 2023	SELL	$338.18 - $362.46 $140,344 - $150,420	-415 Reduced 16.6%	2,085 $725,000
Q2 2023 Aug 09, 2023	BUY	$314.42 - $351.91 $15,092 - $16,891	48 Added 1.96%	2,500 $879,000
Q1 2023 Apr 17, 2023	SELL	$283.23 - $323.1 $31,155 - $35,541	-110 Reduced 4.29%	2,452 $772,000
Q4 2022 Jan 25, 2023	BUY	$285.76 - $321.48 $17,717 - $19,931	62 Added 2.48%	2,562 $740,000
Q3 2022 Oct 24, 2022	BUY	$273.83 - $305.53 $17,525 - $19,553	64 Added 2.63%	2,500 $724,000
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $74,247 - $92,445	316 Added 14.91%	2,436 $686,000
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $13,452 - $16,982	-76 Reduced 3.46%	2,120 $466,000
Q3 2021 Oct 18, 2021	BUY	$181.39 - $202.99 $15,418 - $17,254	85 Added 4.03%	2,196 $398,000
Q2 2021 Aug 06, 2021	SELL	$187.49 - $221.1 $4,312 - $5,085	-23 Reduced 1.08%	2,111 $426,000
Q1 2021 Apr 27, 2021	BUY	$207.02 - $241.31 $66,246 - $77,219	320 Added 17.64%	2,134 $459,000
Q4 2020 Jan 15, 2021	BUY	$207.01 - $276.09 $27,325 - $36,443	132 Added 7.85%	1,814 $429,000
Q3 2020 Oct 09, 2020	SELL	$255.65 - $303.1 $6,902 - $8,183	-27 Reduced 1.58%	1,682 $458,000
Q2 2020 Jul 08, 2020	BUY	$225.48 - $295.8 $34,949 - $45,849	155 Added 9.97%	1,709 $496,000
Q1 2020 Apr 24, 2020	BUY	$199.77 - $247.81 $20,576 - $25,524	103 Added 7.1%	1,554 $370,000
Q4 2019 Jan 22, 2020	BUY	$166.71 - $223.91 $7,168 - $9,628	43 Added 3.05%	1,451 $340,000
Q3 2019 Oct 23, 2019	BUY	$166.23 - $187.09 $234,051 - $263,422	1,408 New	1,408 $239,000
Q2 2019 Aug 02, 2019	SELL	$164.61 - $190.37 $189,630 - $219,306	-1,152 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $188,616 - $224,294	1,152 New	1,152 $212,000

Others Institutions Holding VRTX

# of Institutions

1,753

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Vertex Pharmaceuticals Inc Transaction History